Vascepa

2 Biotech Stocks Poised for Big Gains in 2019
Motley Fool
Mon, 12/3/18 - 10:42 pm
Amarin
Vascepa
Novavax
ResVax
Amarin raises $200M ahead of Vascepa push
BioCentury
Tue, 11/27/18 - 11:48 pm
Amarin
Vascepa
Amarin's Vascepa trial stirs data debate as stock drops 10%
Biopharma Dive
Mon, 11/12/18 - 11:42 pm
Amarin
Vascepa
Amarin's Fish-Oil-Derived Drug Shows Great Promise — With Big Caveats
Forbes
Sun, 11/11/18 - 09:19 pm
Amarin
Vascepa
Why Amarin Stock Jumped 28% in October -- and Why a Bigger Move Could Come Soon
Motley Fool
Sun, 11/4/18 - 02:33 pm
Amarin
Vascepa
Experts question Amarin's early touting of Vescepa data ahead of detailed results
Endpoints
Fri, 11/2/18 - 11:12 am
Amarin
Vascepa
heart disease
[video+transcript] How Big Could Amarin's Vascepa Be?
Motley Fool
Mon, 10/1/18 - 09:54 am
Vascepa
Amarin
3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph
Yahoo/Motley Fool
Thu, 09/27/18 - 10:07 am
Amarin
Vascepa
Amgen
Sanofi
Regeneron
Amarin Soars as Fish Oil Pill Cuts Risk of Strokes in Long-Awaited Study
Xconomy
Mon, 09/24/18 - 09:37 am
Amarin
fish oil
strokes
Vascepa
Why Amarin Corporation Skyrocketed 23.9% in August
Motley Fool
Tue, 09/4/18 - 09:41 am
Amarin
Vascepa
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Motley Fool
Mon, 09/3/18 - 12:20 pm
Amarin
CRISPR Therapeutics
Geron
Vascepa
Vertex Pharmaceuticals
CTX001
JNJ
imetelstat
Analysts: Amarin poised for huge gains if Vascepa trial comes back positive
Medical Marketing and Media
Mon, 08/6/18 - 11:58 pm
Amarin
Vascepa
Amarin's Vascepa goes on TV to lay groundwork for impending CV outcomes data
Fierce Pharma
Mon, 07/30/18 - 11:32 pm
Amarin
Vascepa
physicians
television ads
Sink or swim for fish oils, and Amarin
EP Vantage
Mon, 07/16/18 - 09:58 am
Amarin
Vascepa
Boom-or-Bust News Is On Tap Soon for Amarin
Motley Fool
Thu, 04/5/18 - 08:54 am
Amarin
Vascepa
triglycerides
Amarin's Salyer preps for Vascepa push
Medical Marketing and Media
Tue, 12/12/17 - 10:55 pm
Amarin
Vascepa
8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St
Sat, 09/3/16 - 12:17 pm
FDA
Achillion
odalasvir
AL-335
simeprevir
Amarin
Vascepa
Array Biopharma
binimetinib
Mast Therapeutics
vepoloxamer
Novavax
Threshold Pharmaceuticals
tarloxotinib
Amarin slips after adding second interim efficacy trial to PhIII CV trial
Fierce Biotech
Thu, 08/4/16 - 09:13 pm
Amarin
clinical trials
Vascepa
This Tiny Biopharma Has Been Bucking The Downtrend
Motley Fool
Mon, 06/27/16 - 03:04 pm
Amarin
Vascepa
Amarin - Vascepa Gains Protection Until At Least 2020
Seeking Alpha
Wed, 06/15/16 - 05:43 pm
Amarin
Vascepa
FDA
market exclusivity

Pages